NCT00491322View on ClinicalTrials.gov

Vitamin D Deficiency, Insulin Resistance and FGF-23

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Vitamin D Deficiency
Interventions
DIETARY_SUPPLEMENT

Ergocalciferol

Ergocalciferol 50000 international units once a week for 12 weeks

DIETARY_SUPPLEMENT

Ergocalciferol placebo

Ergocalciferol placebo once a week for 12 weeks

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00491322 - Vitamin D Deficiency, Insulin Resistance and FGF-23 | Biotech Hunter | Biotech Hunter